Article
A blood-based miRNA signature for early non-invasive diagnosis of preeclampsia
13 Sept 2022
Abstract excerpt
BACKGROUND: Preeclampsia (PE) is a multisystemic maternal syndrome with substantial maternal and fetal morbidity and mortality. Currently, there is no clinically viable non-invasive biomarker assay for early detection, thus limiting the effective prevention and therapeutic strategies for PE. METHODS: We conducted a discovery-training-validation three-phase retrospective and prospective study with cross-platform...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
